Mark Coleman

Director

Mark Coleman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $4.0M of AXSM (25,000 sh × $161.11, as filed), executed Feb 26.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.2M

shares × price, as filed

Last traded

Jun 10

Filed Jun 10

Median ADV $188.5M across their filed names

Open performance→

Volume by month

Buys $102K Sells $9.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

AXSM

Axsome Therapeutics, Inc. AXSM · 1 buy · 5 sells 6 filings

Recent filings

AXSMSALE Axsome Therapeutics, Inc. View filing → $160K
643 sh × $249.00
Exec Jun 10
Filed Jun 10 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $4.0M
17,537 sh across 3 lots
Exec May 29
Filed Jun 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $4.0M
25,000 sh × $161.11
Exec Feb 26
Filed Feb 27 · 5:30 PM ET AXSMPURCHASE Axsome Therapeutics, Inc. View filing → $102K
800 sh × $127.20
Exec Sep 8 2025
Filed Sep 9 2025 · 8:11 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $783K
7,500 sh across 2 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $322K
3,000 sh × $107.49
Exec May 20 2025
Filed May 20 2025 · 5:30 PM ET